Literature DB >> 6115663

Physiological and pharmacological variability in estimated hepatic blood flow in man.

T K Daneshmend, L Jackson, C J Roberts.   

Abstract

1 Changes in hepatic blood flow have been estimated by measurement of single-dose indocyanine green kinetics in groups of healthy individuals. 2 The effects of change in posture, exercise and ingestion of milk on estimated hepatic blood flow have been assessed. 3 The erect posture and exercise significantly decreased ICG clearance. However, no consistent change was noted after ingestion of milk. 4 The effects of the adrenoceptor blocking drugs phenoxybenzamine, propranolol and labetalol on hepatic blood flow were also assessed. 5 Propranolol and labetalol caused a significant fall in ICG clearance in the supine position. Phenoxybenzamine did not show a consistent change. 6 Posture, exercise and adrenoceptor blockade appear to be important variables affecting hepatic blood flow. They should be considered when kinetics of high-clearance drugs are measured, and may provide a useful model for the assessment of the effects of alterations in hepatic blood flow on the clearance of drugs.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115663      PMCID: PMC1401606          DOI: 10.1111/j.1365-2125.1981.tb01155.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  INDOCYANINE GREEN CLEARANCE AND ESTIMATED HEPATIC BLOOD FLOW DURING MILD TO MAXIMAL EXERCISE IN UPRIGHT MAN.

Authors:  L B ROWELL; J R BLACKMON; R A BRUCE
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

3.  The use of indocyanine green for the evaluation of hepatic function and blood flow in man.

Authors:  B D WIEGAND; S G KETTERER; E RAPAPORT
Journal:  Am J Dig Dis       Date:  1960-05

4.  The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects.

Authors:  J L BRANDT; L CASTLEMAN; H D RUSKIN; J GREENWALD; J J KELLY
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

5.  The effect of splanchnic sympathectomy in hypertensive patients upon estimated hepatic blood flow in the upright as contrasted with the horizontal position.

Authors:  R W WILKINS; J W CULBERTSON; F J INGELFINGER
Journal:  J Clin Invest       Date:  1951-03       Impact factor: 14.808

6.  The presence of beta-adrenergic receptors in the hepatic vasculature.

Authors:  A Geumei; M Mahfouz
Journal:  Br J Pharmacol Chemother       Date:  1968-03

Review 7.  Influence of food on the bioavailability of drugs.

Authors:  A Melander
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

8.  Methods of the assessment of the effect of drugs on liver blood flow in man.

Authors:  E E Ohnhaus
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

9.  Effect of food on the bioavailability of labetalol.

Authors:  R Mäntylä; H Allonen; J Kanto; T Kleimola; R Sellman
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

10.  Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism.

Authors:  A J McLean; P J McNamara; P duSouich; M Gibaldi; D Lalka
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

View more
  38 in total

1.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

2.  Effect of pentoxifylline on liver plasma flow in normal man.

Authors:  A Suren; F E Bauer; B Rosenkranz; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Lack of effect of subject posture on intravenous midazolam clearance: implications for hepatic cytochrome P450 3A phenotyping.

Authors:  Joseph D Ma; Anne N Nafziger; William Mylott; David B Haughey; Mario L Rocci; Joseph S Bertino
Journal:  Br J Clin Pharmacol       Date:  2008-12-12       Impact factor: 4.335

4.  Quantitative assessment of hepatic blood flow using intravenous indocyanine green.

Authors:  Joseph D Ma; Anne N Nafziger; William Mylott; David B Haughey; Mario L Rocci; Joseph S Bertino
Journal:  Eur J Clin Pharmacol       Date:  2008-07-02       Impact factor: 2.953

5.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

6.  Hepatic blood flow measurements and indocyanine green kinetics in a chronic dog model.

Authors:  A Skerjanec; D W O'Brien; T K Tam
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

7.  The effect of a single oral dose of ethanol on hepatic blood flow in man.

Authors:  D J Edwards; L M Babiak; H B Beckman
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 8.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

9.  Circadian changes in estimated hepatic blood flow in healthy subjects.

Authors:  B Lemmer; G Nold
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

10.  The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.